The global market for Cannabis is estimated at .5 billion in 2018. It is expected to reach 7.67 billion by 2025 growing at a CAGR of 33.17 percent
The global Medical Cannabis market is expected to jump to .60 billion by 2020 and further grow by a CAGR of 22.84 percent over a period of seven years from 2018 to 2025
Pharmaceutical companies are leading the overall investments being done in cannabis market
The list of companies leading the cannabis sector are Aurora Cannabis Inc., Canopy Growth Corporation, Medmen Enterprises, Tilary Inc., Aphria Inc., AbbVie Inc., GW Pharmaceuticals PLC, AusCann Group Holdings Ltd, Holigen, Inter Cure Ltd, Wayland Group Corp, Scotts-Miracle Gro, Cronos Group Inc., Hexo Corporation, The Green Organic Dutchman, Cann Group, Canopy Rivers, Cann Trust Holdings Inc.. They are making significant investments to buy their way into the market for Cannabis products
R&D Interest in Cannabis technology has significantly up-surged since 2012, concurrently with the two principal research groups publishing their revolutions in the scientific literature
The North American market has the maximum number of companies dealing with Cannabis products or services
Abbvie Inc. holds the largest patent portfolio in cannabis technology with 216 IP assets
North America and Europe are the leading countries in recreational cannabis market
